BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3292038)

  • 1. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.
    Kewenter J; Björk S; Haglind E; Smith L; Svanvik J; Ahrén C
    Cancer; 1988 Aug; 62(3):645-51. PubMed ID: 3292038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial.
    Hardcastle JD; Armitage NC; Chamberlain J; Amar SS; James PD; Balfour TW
    Cancer; 1986 Jul; 58(2):397-403. PubMed ID: 3719535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of a risk questionnaire in screening for colorectal neoplasm.
    Kewenter J; Haglind E; Smith L
    Br J Surg; 1989 Mar; 76(3):280-3. PubMed ID: 2720326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects.
    Kewenter J; Brevinge H; Engarås B; Haglind E; Ahrén C
    Scand J Gastroenterol; 1994 May; 29(5):468-73. PubMed ID: 8036464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening.
    Castiglione G; Biagini M; Barchielli A; Grazzini G; Mazzotta A; Salvadori P; Scillone L; Ciatto S
    Br J Cancer; 1993 May; 67(5):1142-4. PubMed ID: 8494714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved screening for colorectal cancer by immunological detection of occult blood.
    Frommer DJ; Kapparis A; Brown MK
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1092-4. PubMed ID: 3132220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient compliance with screening for fecal occult blood in family practice.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    CMAJ; 1987 Aug; 137(3):195-8. PubMed ID: 3607662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of the hemoccult as a screening test in patients taking anticoagulants.
    Kewenter J; Svanvik J; Svensson C; Wållgren K
    Cancer; 1984 Dec; 54(12):3054-8. PubMed ID: 6498780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological detection of occult blood in bowel cancer patients.
    Kapparis A; Frommer D
    Br J Cancer; 1985 Dec; 52(6):857-61. PubMed ID: 3935151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of faecal occult blood testing in the detection of colorectal cancer.
    Hardcastle JD; Farrands PA; Balfour TW; Chamberlain J; Amar SS; Sheldon MG
    Lancet; 1983 Jul; 2(8340):1-4. PubMed ID: 6134884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial.
    Kewenter J; Brevinge H; Engarås B; Haglind E; Ahrén C
    Dis Colon Rectum; 1994 Feb; 37(2):115-9. PubMed ID: 8306829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.
    Winawer SJ; Andrews M; Flehinger B; Sherlock P; Schottenfeld D; Miller DG
    Cancer; 1980 Jun; 45(12):2959-64. PubMed ID: 6992968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention.
    Friedman LC; Everett TE; Peterson L; Ogbonnaya KI; Mendizabal V
    J Cancer Educ; 2001; 16(2):85-8. PubMed ID: 11440068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
    Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
    J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal occult blood testing in the detection of colorectal cancer.
    Elliot MS; Levenstein JH; Wright JP
    Br J Surg; 1984 Oct; 71(10):785-6. PubMed ID: 6487979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.
    Kronborg O; Fenger C; Olsen J; Bech K; Søndergaard O
    Scand J Gastroenterol; 1989 Jun; 24(5):599-606. PubMed ID: 2762760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.